BACKGROUND: Due to the characteristics of short half-life, fast metabolism and direct effect to the tumor cells, controlled release formulation is applied to anti-tumor treatment. Fluorouracil controlled release formulation is characterized by long-term drug action, maximum drug concentration in the area of the target lesion, low systemic adverse reaction, as well as low damage to the liver.
OBJECTIVE: Using literature search and the depth of analysis capabilities of Wanfang database, to analyze the data trends in the study of fluorouracil controlled release formulation, and to explore the safety after its implantation.
DESIGN: Bibliometric data analysis.
DATA RETRIEVAL: A search of related literature of fluorouracil controlled release formulation was performed in Wanfang database, with key words of “controlled release formulation”, “fluorouracil”, “antineoplastic” and “biomaterial”, from 2002-01 to 2011-12. The retrieval results were analyzed, and the trends were described in words and graphics.
SELECTION CRITERIA: Inclusive criteria: ①Basic research papers related to fluorouracil controlled release formulation. ②Papers related to the controlled release formulation for anti-tumor treatment. ③Papers related to the security issues after implantation of fluorouracil controlled release formulation. Exclusive criteria: ①Literature has nothing to do with the purpose of this review. ②Duplication of research literature. ③Journal’s own information. ④Unpublished papers. ⑤The article needs to be retrieved by phone or manual searches. ⑥The literature focuses on nursing.
MAIN OUTCOME MEASUREMENTS: The literatures were analyzed by data trends published year, literature number, subject category, research institutions, source journals, literature citations, literature download frequency, associated literature, distribution of the author, distribution of the funding and major keywords. The Ph.D. thesis, outstanding master’s degree papers, conference papers, and the clinical applications of fluorouracil controlled release formulation were analyzed as well as the safety after implantation.
RESULTS: A total of 49 research literatures related to fluorouracil controlled release formulation were retrieved in Wanfang database during 2002-2011. The number of papers was in the steady state. Most of literatures were published in 2008 (n=8). And the literatures were focused on pharmaceutical discipline. Zhongguo Yiyao Gongye Zazhi published more literatures than others. A total of 32 projects were supported by funding, and most of them supported by the National Natural Science Foundation of China. The frequently used subject words and key words are “fluorouracil”, “chitosan” and “nanoparticles”, respectively. In many literatures, chitosan is selected as a carrier, and fluorouracil-loaded chitosan nanoparticle for drug delivery is the focus of the study. Fluorouracil controlled release formulation has a certain effect in the treatment of esophagus, cardia, gastric cancer, colon cancer, breast cancer, which is a safe and effective treatment.
CONCLUSION: The bibliometric data analysis on fluorouracil controlled release formulation in Wanfang database and summary on safety after implantation can provide valuable reference for Chinese medical workers in both basic research and clinical study of anti-tumor controlled release formulation.